SM_239a: Scleroderma Flashcards
Rodnan skin score is ____
Rodnan skin score is semi-quantitative measure of the extent of skin induration (fibrosis)
- Normal skin: 0
- Unable to pinch skin: 3+
- Max score is 51 (because 17 sites)
+ANA with _____ pattern is specific for systemic sclerosis
+ANA with nucleolar pattern is specific for systemic sclerosis
(note that ANA is positive in some healthy people)
Describe systemic sclerosis
Systemic sclerosis
- Chronic multi-system disease
- Orphan disease
- Much more common in females, especially in post-childbearing years
- Heterogeneous: multiple disease subsets or endophenotypes (diffuse cutaneous, limited cutaneous)
Describe the major organ manifestations of systemic sclerosis
Systemic sclerosis
- Two types: limited cutaneous and diffuse cutaneous
- Oral, upper GI, lower GI, MSK, pulmonary, cardiac, renal, skin, and vascular
- Small to medial vasculopathy in fingers -> digital necrosis
- Severe hypomotility in GI
- Watermelon stomach
- Honeycombing or ground glass in lung
- Onion skinning in kidney (no lumen left): increased ischemia, increased renin, and repeat
- Soft tissue calcifications
Describe limited cutaneous systemic sclerosis
Limited cutaneous systemic sclerosis
- CREST: calcinosis, Raynaud, esophageal involvement, sclerodactyly, telangiectasia
- Antibody: anticentromere
- Slow progression
- Better prognosis
- Long survival
Limited cutaneous systemic sclerosis is also called ____ because of ____, ____, ____, ____, and ____
Limited cutaneous systemic sclerosis is also called CREST because of calcinosis, Raynaud, esophageal involvement, sclerodactyly, and telangiectasia
Limited cutaneous systemic sclerosis antibody is ____
Limited cutaneous systemic sclerosis antibody is anticentromere
Describe diffuse cutaneous systemic sclerosis
Diffuse cutaneous systemic sclerosis
- Diffuse skin induration
- Truncal involvement
- Antibody: anti-topoisomerase
- Rapid progression
- Poor prognosis
- Poor survival
Diffuse cutaneous systemic sclerosis is ____
Diffuse cutaneous systemic sclerosis is anti-topoisomerase
Diffuse cutaneous systemic sclerosis has a ____ progression, ____ prognosis, and ____ survival than lateral cutaneous systemic sclerosis
Diffuse cutaneous systemic sclerosis has a more rapid progression, worse prognosis, and poorer survival than lateral cutaneous systemic sclerosis
Systemic sclerosis is characterized by ____ pathogenesis comprised of ____, ____, and ____
Systemic sclerosis is characterized by tripartite pathogenesis comprised of immune, vascular, and fibrotic
(vascular and fibrotic complications account for high mortality)
Describe pathogenesis of systemic sclerosis
Systemic sclerosis pathogenesis
- Microangiopathy (small blood vessels): Raynaud phenomenon, pulmonary arterial hypertension, scleroderma renal crisis, and mucocutaneous telangiectasia
- Inflammation and autoimmunity: T cells, B cells, monocytes / macrophages, dendritic cells; cytokines, adipkines, chemokines; ANA, highly disease-specific autoantibodies
- Fibrosis (scar) in multiple organs: skin, pulmonary, heart, GI, tendons
Vascular pathogenesis of systemic sclerosis is _____
Vascular pathogenesis of systemic sclerosis is microangiopathy (small blood vessels)
- Raynaud phenomenon
- Pulmonary arterial hypertension
- Scleroderma renal crisis
- Mucocutaneous telangiectasia
Immune pathogenesis of systemic sclerosis involves ____ and ____
Immune pathogenesis of systemic sclerosis involves inflammation and autoimmunity
- T cells, B cells, monocytes/macrophages, dendritic cells
- Cytokines, adipokines, chemokines
- Plasma cells: ANA, disease-specific autoantibodies
Fibrotic pathogenesis in systemic sclerosis involves _____
Fibrotic pathogenesis in systemic sclerosis involves fibrosis in multiple organs
- Skin fibrosis
- Pulmonary fibrosis, also heart / GI / tendon fibrosi